PH12017502369A1 - A delayed release drug formulation - Google Patents

A delayed release drug formulation

Info

Publication number
PH12017502369A1
PH12017502369A1 PH12017502369A PH12017502369A PH12017502369A1 PH 12017502369 A1 PH12017502369 A1 PH 12017502369A1 PH 12017502369 A PH12017502369 A PH 12017502369A PH 12017502369 A PH12017502369 A PH 12017502369A PH 12017502369 A1 PH12017502369 A1 PH 12017502369A1
Authority
PH
Philippines
Prior art keywords
delayed release
polymeric material
soluble polymeric
inner layer
layer comprises
Prior art date
Application number
PH12017502369A
Inventor
Gonzalez Roberto Carlos Bravo
Thomas Buser
Fr‚D‚Ric Jean-Claude Goutte
Abdul Waseh Basit
Felipe Jos‚ Oliveria Varum
Ana Cristina Freire
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12166110.2A external-priority patent/EP2659881B1/en
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of PH12017502369A1 publication Critical patent/PH12017502369A1/en

Links

Abstract

In a delayed release formulation comprising a core containing a drug and a delayed release coating for providing intestinal release, release of the drug in the colon is accelerated by including an isolation layer between the core and the delayed release coating. The delayed release coating comprises an inner layer and an outer layer. The outer layer comprises a pH dependently soluble polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a soluble polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said soluble polymeric material being selected from the group consisting of a polycarboxylic acid polymer that is at least partially neutralised, and a non-ionic polymer, provided that, where said soluble polymeric material is a non-ionic polymer, said inner layer comprises at least one additive selected from a buffer agent and a base.
PH12017502369A 2012-04-30 2017-12-20 A delayed release drug formulation PH12017502369A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261640217P 2012-04-30 2012-04-30
EP12166110.2A EP2659881B1 (en) 2012-04-30 2012-04-30 A delayed release drug formulation
PCT/EP2013/058923 WO2013164316A1 (en) 2012-04-30 2013-04-29 A delayed release drug formulation

Publications (1)

Publication Number Publication Date
PH12017502369A1 true PH12017502369A1 (en) 2020-09-28

Family

ID=54196716

Family Applications (3)

Application Number Title Priority Date Filing Date
PH12017502369A PH12017502369A1 (en) 2012-04-30 2017-12-20 A delayed release drug formulation
PH12018500304A PH12018500304B1 (en) 2012-04-30 2018-02-12 A delayed release drug formulation
PH12018501311A PH12018501311A1 (en) 2012-04-30 2018-06-19 A delayed release drug formulation

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH12018500304A PH12018500304B1 (en) 2012-04-30 2018-02-12 A delayed release drug formulation
PH12018501311A PH12018501311A1 (en) 2012-04-30 2018-06-19 A delayed release drug formulation

Country Status (10)

Country Link
JP (2) JP6700220B2 (en)
CL (2) CL2017001990A1 (en)
CU (2) CU24343B1 (en)
CY (1) CY1121470T1 (en)
EC (2) ECSP14028079A (en)
HK (3) HK1202267A1 (en)
HR (3) HRP20190470T1 (en)
IL (2) IL235282A (en)
PH (3) PH12017502369A1 (en)
ZA (1) ZA201407675B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3662902A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662900A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
CN113493220A (en) * 2020-04-02 2021-10-12 杨洋 Hollow metal oxide microsphere, preparation method thereof and drug sustained-release application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422121A (en) * 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
BRPI0721654B8 (en) * 2007-05-07 2022-07-05 Evonik Roehm Gmbh solid dosage forms comprising an enteric coating with accelerated drug release, their method of manufacture and use
SI2659881T1 (en) * 2012-04-30 2018-03-30 Tillotts Pharma Ag A delayed release drug formulation

Also Published As

Publication number Publication date
JP6700220B2 (en) 2020-05-27
CY1121470T1 (en) 2020-05-29
IL235282A (en) 2017-09-28
CL2017001990A1 (en) 2018-03-16
HRP20190470T1 (en) 2019-05-17
HRP20192210T1 (en) 2020-02-21
PH12018500304A1 (en) 2018-09-24
JP2017145268A (en) 2017-08-24
ECSP14028079A (en) 2015-12-31
HK1202267A1 (en) 2015-09-25
IL235283A (en) 2017-09-28
CU24343B1 (en) 2018-05-08
CU20160014A7 (en) 2016-04-25
HRP20190727T1 (en) 2019-06-14
JP2017145267A (en) 2017-08-24
CU24342B1 (en) 2018-05-08
CU20160026A7 (en) 2016-05-30
HK1202266A1 (en) 2015-09-25
JP6626470B2 (en) 2019-12-25
PH12018501311A1 (en) 2020-09-14
PH12018500304B1 (en) 2018-09-24
ZA201407675B (en) 2016-05-25
HK1244435B (en) 2019-10-25
ECSP14028077A (en) 2015-12-31
CL2017001989A1 (en) 2018-03-16

Similar Documents

Publication Publication Date Title
PH12016500307A1 (en) A delayed release drug formulation
JOP20200145B1 (en) A delayed release drug formulation
PH12017502369A1 (en) A delayed release drug formulation
MX343433B (en) Antimicrobial/antibacterial medical devices coated with traditional chinese medicines.
GEP20207119B (en) A delayed release drug formulation
MX2019002162A (en) Formulation of a drug for delayed-release.
PE20160211A1 (en) DELAYED RELEASE DRUG FORMULATION